Investigation on pharmacokinetics, tissue distribution and excretion of 1-triacontanol in rats by gas chromatography-tandem mass spectrometry (GC-MS/MS). (January 2015)
- Record Type:
- Journal Article
- Title:
- Investigation on pharmacokinetics, tissue distribution and excretion of 1-triacontanol in rats by gas chromatography-tandem mass spectrometry (GC-MS/MS). (January 2015)
- Main Title:
- Investigation on pharmacokinetics, tissue distribution and excretion of 1-triacontanol in rats by gas chromatography-tandem mass spectrometry (GC-MS/MS)
- Authors:
- Wang, Chunfeng
Fan, Ali
Deng, Shuhua
Gao, Wenchao
Zhang, Wei
Yang, Wei
Zhu, Xiaojie
Lu, Yang
Chen, Xijing - Abstract:
- <abstract> <title>Abstract</title> <p>1. 1-Triacontanol (TA) recently shows promising anti-tumor activity. The present study was aimed to develop a sensitive gas chromatography-tandem mass spectrometry method to explore the pharmacokinetic profiles, distribution and excretion of TA in Sprague-Dawley rats after oral administration of TA. Chromatography separation was performed on a HP-5MS column. 1-Octacosanal was used as the internal standard (IS). Quantification of TA and IS was carried out at <italic>m</italic>/<italic>z</italic> 495.6 → 97.0 and <italic>m</italic>/<italic>z</italic> 467.5 → 97.0, respectively, in positive electron ionization and multiple reaction monitoring mode. The pharmacokinetic parameters were calculated by non-compartmental analysis.</p> <p>2. The area under concentration-time curve AUC<sub>0–6 h</sub> and AUC<sub>0–∞</sub> for TA at 60 mg/kg were 87.737±13.574 and 93.617±17.62, respectively. The mean residence time was 3.25 ± 0.17 h. In addition, the elimination half-lives (<italic>t</italic><sub>1/2</sub>) were (2.37±1.23, 1.27±0.49, 2.07±0.93) h after single oral administration of 30, 60 and 120 mg/kg of TA. After oral administration, TA was extensively distributed in stomach and intestine. The majority of TA excreted via feces, and its accumulative excretion ratio during the period of 72 h was 26.68 ± 7.14%, but only 0.0023 ± 0.0015% and 0.0027 ± 0.0006% for urines and bile, respectively. The absolute bioavailability (<italic>F</italic>, %) of<abstract> <title>Abstract</title> <p>1. 1-Triacontanol (TA) recently shows promising anti-tumor activity. The present study was aimed to develop a sensitive gas chromatography-tandem mass spectrometry method to explore the pharmacokinetic profiles, distribution and excretion of TA in Sprague-Dawley rats after oral administration of TA. Chromatography separation was performed on a HP-5MS column. 1-Octacosanal was used as the internal standard (IS). Quantification of TA and IS was carried out at <italic>m</italic>/<italic>z</italic> 495.6 → 97.0 and <italic>m</italic>/<italic>z</italic> 467.5 → 97.0, respectively, in positive electron ionization and multiple reaction monitoring mode. The pharmacokinetic parameters were calculated by non-compartmental analysis.</p> <p>2. The area under concentration-time curve AUC<sub>0–6 h</sub> and AUC<sub>0–∞</sub> for TA at 60 mg/kg were 87.737±13.574 and 93.617±17.62, respectively. The mean residence time was 3.25 ± 0.17 h. In addition, the elimination half-lives (<italic>t</italic><sub>1/2</sub>) were (2.37±1.23, 1.27±0.49, 2.07±0.93) h after single oral administration of 30, 60 and 120 mg/kg of TA. After oral administration, TA was extensively distributed in stomach and intestine. The majority of TA excreted via feces, and its accumulative excretion ratio during the period of 72 h was 26.68 ± 7.14%, but only 0.0023 ± 0.0015% and 0.0027 ± 0.0006% for urines and bile, respectively. The absolute bioavailability (<italic>F</italic>, %) of TA was about 2.0%.</p> </abstract> … (more)
- Is Part Of:
- Xenobiotica. Volume 45:Number 1(2015:Jan.)
- Journal:
- Xenobiotica
- Issue:
- Volume 45:Number 1(2015:Jan.)
- Issue Display:
- Volume 45, Issue 1 (2015)
- Year:
- 2015
- Volume:
- 45
- Issue:
- 1
- Issue Sort Value:
- 2015-0045-0001-0000
- Page Start:
- 71
- Page End:
- 78
- Publication Date:
- 2015-01
- Subjects:
- Metabolism -- Periodicals
Drugs -- Physiological effect -- Periodicals
Food additives -- Periodicals
Chemicals -- Physiological effect -- Periodicals
Biochemistry -- Periodicals
Pharmaceutical Preparations -- metabolism -- Periodicals
Metabolism -- Periodicals
574.133 - Journal URLs:
- http://informahealthcare.com/journal/xen ↗
http://informahealthcare.com ↗ - DOI:
- 10.3109/00498254.2014.943334 ↗
- Languages:
- English
- ISSNs:
- 0049-8254
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 9367.020000
British Library DSC - BLDSS-3PM
British Library STI - ELD Digital store - Ingest File:
- 4026.xml